Menu
Platform
Solution
Turnkey Multidisciplinary Cancer (MDC) Care Solution
Advanced Tumor Board/MDT Management
Network and Referral Expansion
Patient Tracking, Quality and Accreditation
Patient Loyalty and Survivorship Planning
Cancer Data Access and Insights
Resources
Blog
Case Studies
Education
CME
News
Events
About
Meet Our Leadership Team
Meet Our Board of Directors
Awards
Contact Us
Careers
Platform
Solution
Turnkey Multidisciplinary Cancer (MDC) Care Solution
Advanced Tumor Board/MDT Management
Network and Referral Expansion
Patient Tracking, Quality and Accreditation
Patient Loyalty and Survivorship Planning
Cancer Data Access and Insights
Resources
Blog
Case Studies
Education
CME
News
Events
About
Meet Our Leadership Team
Meet Our Board of Directors
Awards
Contact Us
Careers
SCHEDULE A DEMO
Home
Resources
Education
Blog
Case Studies
Education
CME
News
Education
Molecular Testing in the Community Oncology Setting
Topics —
Breast Cancer
,
Gastric Cancer
,
Lung Cancer
,
NSCLC
Jun 1, 2021
|
Education
Lung Cancer Patient with 3 EGFR Mutations
Topics —
EGFR
,
Lung Cancer
Apr 1, 2021
|
Education
Ovarian Cancer Patient with Somatic BRCA1 Reversion Mutation
Topics —
BRCA
,
Ovarian Cancer
Apr 1, 2021
|
Education
Ovarian and Lung Cancer Patients with BRCA Reversion and Three EGFR Mutations
Topics —
BRCA
,
EGFR
,
Lung Cancer
,
Ovarian Cancer
Apr 1, 2021
|
Education
NCCN updates: Stage IB – IIA NSCLC with EGFR Alteration Patients
Topics —
EGFR
,
Exon 19 Deletion
,
Lung Cancer
,
NSCLC
Mar 1, 2021
|
Education
Stage IA3 Patient with EGFR Exon 19 Deletion Alteration and High-risk DetermaRx Result
Topics —
EGFR
,
Exon 19 Deletion
,
Lung Cancer
Mar 1, 2021
|
Education
NSCLC Patient and Adjuvant Chemotherapy
Topics —
EGFR
,
Lung Cancer
,
NSCLC
Mar 1, 2021
|
Education
Patient with Possible Synchronous Early-stage NSCLC and Different DetermaRx Results
Topics —
Lung Cancer
,
NSCLC
Feb 1, 2021
|
Education
Patient with NSCLC Who Recurred within a Year
Topics —
EGFR
,
Lung Cancer
,
NSCLC
Feb 1, 2021
|
Education
Patient with Stage IB NSCLC, an Oncocyte DetermaRx High-Risk Result and an EGFR Exon 19 Deletion
Topics —
EGFR
,
Exon 19 Deletion
,
Lung Cancer
,
NSCLC
Feb 1, 2021
|
Education
Stratification of Early-Stage, Non-squamous NSCLC Patients Likely to Benefit from Early, Post-operative Chemotherapy
Topics —
EGFR
,
Exon 19 Deletion
,
Lung Cancer
,
NSCLC
Feb 1, 2021
|
Education
MTC: Patient with Stomach Cancer and KIT exon 11 and ATM Mutations
Topics —
ATM
,
Gastric Cancer
,
KIT Exon 11
Dec 1, 2020
|
Education
Patient with Prostate Cancer and CDK12 and TP53 Mutations
Topics —
CDK12
,
Prostate Cancer
,
TP53
Dec 1, 2020
|
Education
MTB Discussion for Patients with KIT and CDK12 Mutations
Topics —
ATM
,
CDK12
,
Gastric Cancer
,
KIT Exon 11
,
Prostate Cancer
,
TP53
Dec 1, 2020
|
Education
Overview of New CoC Standards
Topics —
CoC
Jan 1, 2020
|
Education